[1] 陈曦. 分化型甲状腺癌术前影像及穿刺病理诊断评估[J]. 中华普外科手术学杂志(电子版), 2016, 10(5):368-372. [2] 王春梅, 王利利. 超声造影参数与分化型甲状腺癌肿瘤组织中增殖基因表达及淋巴结转移的关联性分析[J]. 影像科学与光化学, 2020, 38(6):1076-1081. [3] 赵堃, 崔秋丽, 严昆, 等. 常规超声及超声造影参数对甲状腺乳头状癌被膜侵犯的评估[J]. 中国超声医学杂志, 2020, 36(1):4-7. [4] 王兴, 李伟文, 邵明涛, 等. 分化型甲状腺癌中央区淋巴结转移患者临床病理特征及转移危险因素分析[J]. 肿瘤研究与临床, 2020, 32(7):493-497. [5] 李阳, 郭婕, 苏蕾, 等. 超微血管三维立体超声成像在甲状腺良恶性结节鉴别诊断中的应用价值[J]. 蚌埠医学院学报, 2020, 45(4):93-96. [6] 贾颍辉, 冯桂婷, 宋鑫, 等. 剪切波弹性成像与三维能量多普勒超声在甲状腺良恶性结节中的诊断价值对比[J]. 中国现代普通外科进展, 2020, 23(1):39-41. [7] 中华医学超声杂志(电子版)编辑委员会浅表器官学组. 甲状腺结节超声诊断规范[J]. 中华医学超声杂志(电子版), 2017, 14(4):241-244. [8] Xue W L, Zhou X L, Wei H, et al. Three-dimensional ultrasound technology combined with tomographic ultrasound imaging and volume contrast imaging in diagnosis of solid liver masses[J]. Chinese Journal of Medical Imaging Technology, 2013, 29(4):591-594. [9] Al-Chalabi H, Karthik S, Vaidyanathan S. Radiological-pathological correlation of the British Thyroid Association ultrasound classification of thyroid nodules:A real-world validation study[J]. Clinical Radiology, 2019, 74(9):702-711. [10] Rogers S, Lowe C, Carreira J, et al. Comparison of contrast-enhanced tomographic 3-D ultrasound against rotational angiography imaging immediately after endovascular aneurysm repair[J]. Ultrasound in Medicine & Biology, 2019, 45(9):2356-2362. [11] 刘如玉. 甲状腺结节的三维超声成像及恶性风险评估[D]. 北京:北京协和医学院, 2018:11-12. [12] 桂霜, 李蒙森, 石有振, 等. 三维超声在早期异位妊娠中的应用价值[J]. 实用医学杂志, 2019, 35(15):2469-2473. [13] Bredahl K K, Taudorf M, Ghulam Q M, et al. Three- and two-dimensional ultrasound is as accurate as computed tomography in aortic sac assessment after endovascular aortic repair[J]. Annals of Vascular Surgery, 2021, 72:321-329. [14] Zhao R N, Zhang B, Yang X, et al. Diagnostic value of contrast-enhanced ultrasound of thyroid nodules coexisting with Hashimoto's thyroiditis[J]. Acta Academiae Medicinae Sinicae, 2015, 37(1):66-70. [15] Zhang J J, Zhang X T, Meng Y N, et al. Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules:An updated meta-analysis with comprehensive heterogeneity analysis[J]. PLoS One, 2020, 15(4):e0231775. [16] Gao Z X, Lu Q, Yan J P. Value of differential diagnosis of contrast-enhanced ultrasound in benign and malignant thyroid nodules with microcalcification[J]. Oncology Letters, 2019, 17(5):4545-4549. [17] Eun Y G, Lee Y C, Lee J W. Abstract 5280:A polymorphism of VEGFA is associated with susceptibility to extrathyroidal invasion of papillary thyroid cancer[J]. Cancer Research, 2015, 75(15):5280-5280. [18] Rowe C W, Dill T, Griffin N, et al. Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion[J]. Scientific Reports, 2020, 10(1):1539-1540. [19] 陈为, 谢芳, 张明博, 等. 超声引导125I粒子植入治疗碘难治性分化型甲状腺癌[J]. 中国医学影像学杂志, 2020, 28(1):26-30. [20] Zhu Q D, Shao Z Y, Zhang X, et al. Correlation between ultrasonic features of medullary thyroid carcinoma and cervical lymph node metastasis[J]. Ultrasound in Medicine & Biology, 2021, 47(4):967-972. |